Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Cathomas

Showing results (21-30 of 139) with videos related to

Pageof 14
Sort By:
Onkologie|April 8, 2006
Minimal change glomerulonephritis in chronic lymphocytic leukemia: pathophysiological and therapeutic aspectsMeritxell Garcia Alzamora, Markus Schmidli, Urs Hess, et al.
Irish Journal of Medical Science|March 22, 2023
Role of apalutamide in the treatment landscape for patients with advanced prostate cancer: an expert opinion statement of European clinical practiceMartin Bögemann, Gaetano Facchini, Thomas Bauernhofer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2010
Metastatic angiosarcoma arising from the right atrium: unusual presentation and excellent response to treatment in a young patientMartin Fehr, Max Kuhn, Kurt Mayer, et al.
Onkologie|December 8, 2007
Severe hyponatremia in a patient with mantle cell lymphoma treated with bortezomib: a case report and review of the literatureStefan Brodmann, Evelyne Gyr Klaas, Richard Cathomas, et al.
Frontiers in Oncology|September 16, 2024
PD-L1 expression and correlation with outcome in muscle-invasive and metastatic urothelial carcinoma: review and critical discussionTämer El Saadany, Anja Lorch, Matthew I Milowsky, et al.
Oncology|December 23, 2014
RANK ligand blockade with denosumab in combination with sorafenib in chemorefractory osteosarcoma: a possible step forward?Richard Cathomas, Christian Rothermundt, Beata Bode, et al.
Oncology Research and Treatment|November 28, 2014
Efficacy of triplet combination chemotherapy with oxaliplatin, irinotecan and capecitabine (OCX) in metastatic colorectal cancer in relation to RAS/RAF mutation status: results of a retrospective analysisStefan Brunner, Roger von Moos, Ulrich Mey, et al.
Hematological Oncology|April 23, 2015
Improved survival of older patients with multiple myeloma in the era of novel agentsUlrich J M Mey, Christoph Leitner, Christoph Driessen, et al.
Onkologie|October 10, 2009
Primary manifestation of small lymphocytic lymphoma in the prostateMartin Fehr, Arnoud Templeton, Sergio Cogliatti, et al.
Pathology, Research and Practice|July 21, 2009
Extensive extranodal metastases of basal-like breast cancer with predominant myoepithelial spindle cell differentiationRoman Trepp, Barbara C Padberg, Zsuzsanna Varga, et al.
Pageof 14

Showing results (21-30 of 139) with videos related to

Sort By:
Pageof 14
Onkologie|April 8, 2006
Minimal change glomerulonephritis in chronic lymphocytic leukemia: pathophysiological and therapeutic aspectsMeritxell Garcia Alzamora, Markus Schmidli, Urs Hess, et al.
Irish Journal of Medical Science|March 22, 2023
Role of apalutamide in the treatment landscape for patients with advanced prostate cancer: an expert opinion statement of European clinical practiceMartin Bögemann, Gaetano Facchini, Thomas Bauernhofer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2010
Metastatic angiosarcoma arising from the right atrium: unusual presentation and excellent response to treatment in a young patientMartin Fehr, Max Kuhn, Kurt Mayer, et al.
Onkologie|December 8, 2007
Severe hyponatremia in a patient with mantle cell lymphoma treated with bortezomib: a case report and review of the literatureStefan Brodmann, Evelyne Gyr Klaas, Richard Cathomas, et al.
Frontiers in Oncology|September 16, 2024
PD-L1 expression and correlation with outcome in muscle-invasive and metastatic urothelial carcinoma: review and critical discussionTämer El Saadany, Anja Lorch, Matthew I Milowsky, et al.
Oncology|December 23, 2014
RANK ligand blockade with denosumab in combination with sorafenib in chemorefractory osteosarcoma: a possible step forward?Richard Cathomas, Christian Rothermundt, Beata Bode, et al.
Oncology Research and Treatment|November 28, 2014
Efficacy of triplet combination chemotherapy with oxaliplatin, irinotecan and capecitabine (OCX) in metastatic colorectal cancer in relation to RAS/RAF mutation status: results of a retrospective analysisStefan Brunner, Roger von Moos, Ulrich Mey, et al.
Hematological Oncology|April 23, 2015
Improved survival of older patients with multiple myeloma in the era of novel agentsUlrich J M Mey, Christoph Leitner, Christoph Driessen, et al.
Onkologie|October 10, 2009
Primary manifestation of small lymphocytic lymphoma in the prostateMartin Fehr, Arnoud Templeton, Sergio Cogliatti, et al.
Pathology, Research and Practice|July 21, 2009
Extensive extranodal metastases of basal-like breast cancer with predominant myoepithelial spindle cell differentiationRoman Trepp, Barbara C Padberg, Zsuzsanna Varga, et al.
Pageof 14